| 标题 |
[求助补充材料]
 Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study |
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Nole
馨馨的科科
8R60d8
arniu2008
xing_xing
XX
超帅的笑蓝
OK
学术文献互助
huang
aajhajkahna
修仙中
aaaa
三三三
leery
Kao
Literature
Dean
皖公网安备34019202002308
